- Published on
Emergency and Acute Medicine - Tachydysrhythmias
Tachydysrhythmias refer to any disturbance of cardiac rhythm resulting in a heart rate greater than 100 beats per minute. They encompass a broad spectrum of arrhythmias originating from different parts of the cardiac conduction system, ranging from relatively benign sinus tachycardia to life-threatening ventricular fibrillation. The classification is typically based on the origin of the rhythm and the width of the QRS complex, distinguishing between supraventricular and ventricular causes.
Sinus tachycardia is a narrow-complex, regular rhythm usually between 100 and 150 beats per minute and represents a physiologic response to stressors such as hypovolemia, hypoxia, pain, anxiety, infection, or anemia. It results from increased sympathetic activity or reduced vagal tone and should prompt evaluation for an underlying cause rather than primary rhythm management.
Supraventricular tachycardias (SVTs) originate above the His bundle and may be regular or irregular. Regular SVTs include atrial tachycardia and junctional tachycardia, while irregular SVTs include atrial fibrillation, atrial flutter, and multifocal atrial tachycardia. Atrial fibrillation is the most common pathologic SVT encountered in emergency settings and is characterized by an irregularly irregular rhythm without distinct P waves. Atrial flutter typically demonstrates a sawtooth pattern on ECG. These rhythms are often associated with conditions such as hypertension, coronary artery disease, valvular disease, pulmonary disorders, or metabolic abnormalities.
Ventricular tachycardia (VT) is defined as three or more consecutive ventricular beats at a rate exceeding 100 beats per minute and is commonly associated with structural heart disease, particularly prior myocardial infarction. It may present as monomorphic or polymorphic VT and can rapidly deteriorate into ventricular fibrillation (VF), a chaotic rhythm with no effective cardiac output and a leading cause of sudden cardiac death. Torsades de pointes is a specific form of polymorphic VT associated with prolonged QT interval and is often triggered by medications or electrolyte imbalances such as hypokalemia or hypomagnesemia.
Clinical presentation varies widely, ranging from asymptomatic episodes to severe symptoms such as palpitations, dizziness, dyspnea, chest pain, syncope, or cardiac arrest. Signs of hemodynamic instability include hypotension, altered mental status, chest pain, and pulmonary edema, and these findings necessitate immediate intervention. A careful history and physical examination should focus on identifying underlying cardiac disease, triggers, and the stability of the patient.
Evaluation begins with assessment of airway, breathing, and circulation, followed by rapid determination of whether the patient is stable or unstable. A 12-lead ECG is essential to classify the rhythm and guide management. Laboratory testing is directed toward identifying underlying causes such as electrolyte disturbances, ischemia, or metabolic abnormalities.
Management depends primarily on the patient’s hemodynamic status and the type of rhythm. Unstable patients require immediate synchronized cardioversion for most tachydysrhythmias or defibrillation in cases of pulseless VT or VF, following advanced cardiac life support protocols. Stable patients with narrow-complex tachycardias may respond to vagal maneuvers or pharmacologic therapy such as adenosine. Atrial fibrillation and flutter are typically managed with rate control using beta-blockers or calcium channel blockers, with consideration of anticoagulation depending on duration and risk factors.
Wide-complex tachycardias should be presumed to be ventricular in origin until proven otherwise, especially in older patients or those with structural heart disease. Antiarrhythmic agents such as amiodarone or procainamide are commonly used, while caution is required with AV nodal blocking agents in the presence of accessory pathways. Torsades de pointes is treated with intravenous magnesium and correction of underlying electrolyte abnormalities.
Patients with serious arrhythmias such as VT, VF, persistent SVT, or suspected cardiac ischemia require hospital admission and monitoring. Those with transient, well-tolerated supraventricular rhythms that resolve without complications may be discharged with appropriate follow-up. Prompt recognition and appropriate management are critical, as tachydysrhythmias can rapidly progress to life-threatening conditions if untreated.
Tachydysrhythmias refer to any disturbance of cardiac rhythm resulting in a heart rate greater than 100 beats per minute. They encompass a broad spectrum of arrhythmias originating from different parts of the cardiac conduction system, ranging from relatively benign sinus tachycardia to life-threatening ventricular fibrillation. The classification is typically based on the origin of the rhythm and the width of the QRS complex, distinguishing between supraventricular and ventricular causes.
Sinus tachycardia is a narrow-complex, regular rhythm usually between 100 and 150 beats per minute and represents a physiologic response to stressors such as hypovolemia, hypoxia, pain, anxiety, infection, or anemia. It results from increased sympathetic activity or reduced vagal tone and should prompt evaluation for an underlying cause rather than primary rhythm management.
Supraventricular tachycardias (SVTs) originate above the His bundle and may be regular or irregular. Regular SVTs include atrial tachycardia and junctional tachycardia, while irregular SVTs include atrial fibrillation, atrial flutter, and multifocal atrial tachycardia. Atrial fibrillation is the most common pathologic SVT encountered in emergency settings and is characterized by an irregularly irregular rhythm without distinct P waves. Atrial flutter typically demonstrates a sawtooth pattern on ECG. These rhythms are often associated with conditions such as hypertension, coronary artery disease, valvular disease, pulmonary disorders, or metabolic abnormalities.
Ventricular tachycardia (VT) is defined as three or more consecutive ventricular beats at a rate exceeding 100 beats per minute and is commonly associated with structural heart disease, particularly prior myocardial infarction. It may present as monomorphic or polymorphic VT and can rapidly deteriorate into ventricular fibrillation (VF), a chaotic rhythm with no effective cardiac output and a leading cause of sudden cardiac death. Torsades de pointes is a specific form of polymorphic VT associated with prolonged QT interval and is often triggered by medications or electrolyte imbalances such as hypokalemia or hypomagnesemia.
Clinical presentation varies widely, ranging from asymptomatic episodes to severe symptoms such as palpitations, dizziness, dyspnea, chest pain, syncope, or cardiac arrest. Signs of hemodynamic instability include hypotension, altered mental status, chest pain, and pulmonary edema, and these findings necessitate immediate intervention. A careful history and physical examination should focus on identifying underlying cardiac disease, triggers, and the stability of the patient.
Evaluation begins with assessment of airway, breathing, and circulation, followed by rapid determination of whether the patient is stable or unstable. A 12-lead ECG is essential to classify the rhythm and guide management. Laboratory testing is directed toward identifying underlying causes such as electrolyte disturbances, ischemia, or metabolic abnormalities.
Management depends primarily on the patient’s hemodynamic status and the type of rhythm. Unstable patients require immediate synchronized cardioversion for most tachydysrhythmias or defibrillation in cases of pulseless VT or VF, following advanced cardiac life support protocols. Stable patients with narrow-complex tachycardias may respond to vagal maneuvers or pharmacologic therapy such as adenosine. Atrial fibrillation and flutter are typically managed with rate control using beta-blockers or calcium channel blockers, with consideration of anticoagulation depending on duration and risk factors.
Wide-complex tachycardias should be presumed to be ventricular in origin until proven otherwise, especially in older patients or those with structural heart disease. Antiarrhythmic agents such as amiodarone or procainamide are commonly used, while caution is required with AV nodal blocking agents in the presence of accessory pathways. Torsades de pointes is treated with intravenous magnesium and correction of underlying electrolyte abnormalities.
Patients with serious arrhythmias such as VT, VF, persistent SVT, or suspected cardiac ischemia require hospital admission and monitoring. Those with transient, well-tolerated supraventricular rhythms that resolve without complications may be discharged with appropriate follow-up. Prompt recognition and appropriate management are critical, as tachydysrhythmias can rapidly progress to life-threatening conditions if untreated.
0 Comments
